This 1½ day CME course is to have experts in the field of cardiovascular genetics detail the important role of genetics, genomics, and pharmacogenetics in the diagnosis, risk stratification, and treatment of diseases affecting the heart and the blood vessels.
Topics will include: Genetics/Genomics 101, pharmacogenetics, gene risk scores, genetic purgatory, the molecular autopsy, and the diagnostic, prognostic, and therapeutic implications of genetic testing for patients with congenital heart disease, long QT syndrome and the other channelopathies, hypertrophic cardiomyopathy and the other cardiomyopathies, coronary heart disease, hyperlipidemias, heart failure, pulmonary hypertension, and the aortopathies.
Unique Features: Audience response system to enhance immediate feedback. Easy access to faculty members. One-on-one interaction. Efforts will be made to introduce the clinical applications using new technology, however, there is no hands-on experience provided. Self-assessment questions to gage outcome. A special workshop will be provided to analyze a genetic test report and to comment on the significance of genetic test results from your patients.
COURSE LEARNING OBJECTIVES
Upon conclusion of this program, participants should be able to:
- Summarize the probabilistic nature of genetic testing and develop a strategy to manage the variant of uncertain significance (VUS) test result
- Identify the impact of genetic testing in the diagnosis, risk stratification, and treatment of patients with heritable cardiomyopathies, channelopathies, and aortopathies
- Determine the role of genetic testing in children and adults with congenital heart disease
- Define genetic markers of atherosclerosis and the role of genetic risk scores (GRS) in risk stratification of coronary heart disease
- Identify the genetic basis of heritable causes of the hyperlipidemias and implications for prevention and familial screening
- Define the role of inheritance in cardiovascular drug response and to utilize genetics to minimize adverse events and maximize drug efficacy
This course is intended for pediatric and adult cardiologists, internists, primary care providers, and nurse practitioners with special interest in the management of patients with CVD, pediatric and adult cardiology trainees, and genetic counselors with an interest in cardiology.
Friday, October 12, 2018
Genetics/Genomics 101 - Increasing the Cardio-Genetics IQ of Practicing Cardiologists/NPs/Trainees/GCs
Diagnostic, Prognostic, and Therapeutic Implications of Genetic Testing for the Cardiomyopathies
Diagnostic, Prognostic, and Therapeutic Implications of Genetic Testing for the Cardiac Channelopathies
Saturday, October 13, 2018
Genetics and/or Pharmacogenetics of Your Patient With...
Role of Genetic Testing for My Patient With...
Michael J. Ackerman, M.D., Ph.D.
Naveen Pereira, M.D.
Iftikhar J. Kullo, M.D.
MAYO CLINIC FACULTY
Johan (Martijn) M. Bos, M.D., Ph.D.
John R. Giudicessi, M.D., Ph.D.
Teresa M. Kruisselbrink, M.S., CGC
Sabrina D. Phillips, M.D.
David J. Tester, B.S.
Elijah Behr, MA, MBBS, M.D., FRCP
As a Jointly Accredited Provider by ACCME, ACPE, and ANCC, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.
NATIONAL PHYSICIAN PAYMENT TRANSPARENCY PROGRAM
Mayo Clinic College of Medicine and Science complies with the requirements of the National Physician Payment Transparency Program OPEN PAYMENTS (Physician Payments Sunshine Act).
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 12.5 .AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Health Care Professionals
A certificate of attendance will be provided to other health care professionals for requesting credits in accordance with state nursing boards, speciality societies, or other professional associations.
Attendees should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 CreditsTM from the sposor of this activity.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee members, please go here.
ABIM MOC POINTS
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared with ABIM through PARS.
MD, PhD, DO, Pharm D
EARLY BIRD RATE - $575
After September 28, 2018 - $675
Fellow, Resident, NP, PA, RN
EARLY BIRD RATE - $450
After September 28, 2018 - $550
If you cancel your participation in this course, your registration fee, less a $75 administration fee, will be refunded when written notification is received by Mayo Clinic CV CME before, Friday, September 28, 2018 (email: email@example.com). No refunds will be made on or after Friday, September 28, 2018. Canceled registrations are non-transferable.
Mayo Clinic CV CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event Mayo Clinic CV CME must cancel or postpone this course, Mayo Clinic CV CME will refund the registration fee, but is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
NO SHOW POLICY
This course is intended to be a live learning experience. If you do not attend this course on-site as a live learner, you will not be allowed access to the materials/lectures during or after the course. No refunds will be given for no-show registrants.
Guest rooms have been reserved for attendees and their guests with special course rates at The Westin Hilton Head. In order to receive the group rate, reservations must be made before the room block is filled or before the expiration date of Monday, September 10, whichever comes first. Reservations will be taken after this date bases on space and rate availability.
The Westin Hilton Head Island
2 Grasslawn Avenue
Hilton Head Island, SC 29928
Group Rate: $235 - Island View - Single/Double + $12 resort fee
Group Code: Mayo Clinic Conference
Phone Reservation: 800-937-8461 or 843-681-4000
Parking at the Hotel
Self-parking complimentary/Valet parking $17 per day
Mayo Clinic Department of Cardiovascular Medicine is not responsible for expenses incurred by an individual who is not confirmed and for whom space is not available at the meeting. Costs incurred by the registrant such as airline or hotel fees or penalties are the responsibility of the registrant.
Lodging and travel arrangements are the sole responsibility of the individual registrant.
GRANTS AND EXHIBITS
At the time of posting, a complete listing of commercial supports (financial or in-kind) was not available. Appropriate acknowledgement will be given to all supporters at the time of the meeting.
This course offers the opportunity for commercial companies to interact with health care providers and highlight their products and services. If you are interested in exhibit space during this course, please contact Sheila Fick. Exhibits will be available for viewing at all scheduled breaks.